Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study

BACKGROUND: Plasma amyloid-β (Aβ) levels are increasingly studied as a potential accessible marker of cognitive impairment and dementia. However, it remains underexplored whether plasma Aβ levels including the novel Aβ peptide 1–38 (Aβ(1–38)) relate to preclinical markers of neurodegeneration and ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Hilal, Saima, Wolters, Frank J., Verbeek, Marcel M., Vanderstichele, Hugo, Kamran Ikram, M., Stoops, Erik, Arfan Ikram, M., Vernooij, Meike W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026500/
https://www.ncbi.nlm.nih.gov/pubmed/29960604
http://dx.doi.org/10.1186/s13195-018-0395-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026500/
https://www.ncbi.nlm.nih.gov/pubmed/29960604
http://dx.doi.org/10.1186/s13195-018-0395-6

Ejemplares similares